• education
Search

Deltyba

Deltyba

delamanid

Manufacturer:

Otsuka

Marketer:

Otsuka
Concise Prescribing Info
Contents
Delamanid
Indications/Uses
As part of an appropriate combination regimen for low risk pulmonary multi-drug resistant TB (MDR-TB) when an effective treatment regimen cannot otherwise be composed for reason of resistance or tolerability.
Click to view Deltyba detailed prescribing information
Dosage/Direction for Use
Adult 100 mg twice daily for 24 wk.
Click to view Deltyba detailed prescribing information
Overdosage
View Deltyba overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Serum albumin <2.8 g/dL. Strong inducers of CYP3A (eg, carbamazepine).
Click to view Deltyba detailed prescribing information
Adverse Reactions
Nausea, vomiting, headache, insomnia, dizziness, tinnitus, hypokalaemia, gastritis, decreased appetite & asthenia.
Click to view Deltyba detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Deltyba detailed prescribing information
Storage
View Deltyba storage conditions for details to ensure optimal shelf-life.
Description
View Deltyba description for details of the chemical structure and excipients (inactive components).
Action
View Deltyba mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Anti-TB Agents
ATC Classification
J04AK06 - delamanid ; Belongs to the class of other drugs used in the systemic treatment of tuberculosis.
Presentation/Packing
Form
Deltyba FC tab 50 mg
Packing/Price
6 × 10's (Rp40,100/film-coated tab)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in